×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
18:00
Introduction
Dr Leïla Bengrine-Lefevre
18:05
Les nouvelles recommandations St-Paul-de-Vence appliquées en vraie vie:
  • Cas clinique d’une patiente en première ligne d’un cancer de l’ovaire avancé
    Dr Fernando Bazan
     
  • Cas Clinique d’une patiente en rechute d’un cancer de l’ovaire avancé
    Dr Leïla Bengrine-Lefevre
19:05
Défauts de la recombinaison homologue (HRD):  définition et perspectives thérapeutiques
Dr Elisabeth Luporsi
19:25
La chirurgie à l’ère des PARP Inhibiteurs
Pr Chérif Akladios
19:55 Conclusion

 

Shooting date : 2021-07-12
Last update : 2021-12-23
1 comment
Join the Discussion
  • mohamed S. merci

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, November 20th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, November 20th 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Wednesday, November 20th 2024 from 08am to 09:30am (GMT+1)
    New York : Wednesday, November 20th 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Wednesday, November 20th 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Wednesday, November 20th 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Wednesday, November 20th 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Wednesday, November 20th 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, November 20th 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Wednesday, November 20th 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Thursday, November 21st 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Thursday, November 21st 2024 from 01am to 02:30am (GMT+1)
    Sydney : Thursday, November 21st 2024 from 02am to 03:30am (GMT+1)
    Wellington : Thursday, November 21st 2024 from 04am to 05:30am (GMT+1)

    Les iPARP dans le cancer de l’ovaire : biologie, rationnel, traitements actuels et perspectives...

    Share
    Wednesday, June 11th 2025 from 12pm to 01pm (GMT+2)
    Honolulu : Wednesday, June 11th 2025 from 12am to 01am (GMT+2)
    San Francisco : Wednesday, June 11th 2025 from 03am to 04am (GMT+2)
    New York : Wednesday, June 11th 2025 from 06am to 07am (GMT+2)
    Buenos Aires : Wednesday, June 11th 2025 from 07am to 08am (GMT+2)
    Reykjavik : Wednesday, June 11th 2025 from 10am to 11am (GMT+2)
    London / Dublin : Wednesday, June 11th 2025 from 11am to 12pm (GMT+2)
    Paris / Berlin : Wednesday, June 11th 2025 from 12pm to 01pm (GMT+2)
    Istanbul : Wednesday, June 11th 2025 from 01pm to 02pm (GMT+2)
    Moscou / Dubaï : Wednesday, June 11th 2025 from 02pm to 03pm (GMT+2)
    Bangkok : Wednesday, June 11th 2025 from 05pm to 06pm (GMT+2)
    Shanghai : Wednesday, June 11th 2025 from 06pm to 07pm (GMT+2)
    Tokyo : Wednesday, June 11th 2025 from 07pm to 08pm (GMT+2)
    Sydney : Wednesday, June 11th 2025 from 09pm to 10pm (GMT+2)
    Wellington : Wednesday, June 11th 2025 from 11pm to 12am (GMT+2)

    Recommandations de Saint Paul de Vence 2025

    Focus cancer de l’endomètre avancé ou en rechute

    Share
    0
    Days
    0
    Hours
    0
    Minutes
    0
    Seconds
    Monday, September 22nd 2025 from 01pm to 01:45pm (GMT+2)
    Honolulu : Monday, September 22nd 2025 from 01am to 01:45am (GMT+2)
    San Francisco : Monday, September 22nd 2025 from 04am to 04:45am (GMT+2)
    New York : Monday, September 22nd 2025 from 07am to 07:45am (GMT+2)
    Buenos Aires : Monday, September 22nd 2025 from 08am to 08:45am (GMT+2)
    Reykjavik : Monday, September 22nd 2025 from 11am to 11:45am (GMT+2)
    London / Dublin : Monday, September 22nd 2025 from 12pm to 12:45pm (GMT+2)
    Paris / Berlin : Monday, September 22nd 2025 from 01pm to 01:45pm (GMT+2)
    Istanbul : Monday, September 22nd 2025 from 02pm to 02:45pm (GMT+2)
    Moscou / Dubaï : Monday, September 22nd 2025 from 03pm to 03:45pm (GMT+2)
    Bangkok : Monday, September 22nd 2025 from 06pm to 06:45pm (GMT+2)
    Shanghai : Monday, September 22nd 2025 from 07pm to 07:45pm (GMT+2)
    Tokyo : Monday, September 22nd 2025 from 08pm to 08:45pm (GMT+2)
    Sydney : Monday, September 22nd 2025 from 10pm to 10:45pm (GMT+2)
    Wellington : Tuesday, September 23rd 2025 from 12am to 12:45am (GMT+2)

    Présentation des recommandations de SPV Ovaire sur le traitement de maintenance

    Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
    Honolulu : Wednesday, February 7th 2024 from 06am to 07:30am (GMT+1)
    San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT+1)
    New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
    Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+1)
    Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+1)
    Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
    Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
    Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
    Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+1)

    Toxicités hématologiques des inhibiteurs de PARP

    Regards croisés oncologue-hématologue-interniste

    Share